中山醫學大學WOS高被引研究時光走廊
CSMU Time Corridor—WOS Highly Cited Research


高被引研究
Highly Cited Research


  1. 2009

    Rudwaleit, M., van der Heijde, D., Landewe, R., Listing, J., Akkoc, N., Brandt, J., . . . Wei, J. C. C., . . . Sieper, J. (2009). The development of assessment of spondyloarthritis international society classification criteria for axial spondyloarthritis (part ii): Validation and final selection.Annals of the Rheumatic Diseases, 68(6), 777-783. doi:10.1136/ard.2009.108233. [Journal Category: Rheumatology; Q1]  

    Times Cited: 1,436
  2. 2011

    Rudwaleit, M., van der Heijde, D., Landewe, R., Akkoc, N., Brandt, J., Chou, C. T., . . . Wei, J. C. C., . . . Sieper, J. (2011). The assessment of spondyloarthritis international society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Annals of the Rheumatic Diseases, 70(1), 25-31. doi:10.1136/ard.2010.133645. [Journal Category: Rheumatology; Q1]  

    Times Cited: 636

    Wen, C. P., Wai, J. P. M., Tsai, M. K., Yang, Y. C., Cheng, T. Y. D., Lee, M. C., . . . Wu, X. F. (2011). Minimum amount of physical activity for reduced mortality and extended life expectancy: A prospective cohort study. Lancet, 378(9798), 1244-1253. doi:10.1016/s0140-6736(11)60749-6. [Journal Category: Medicine, General & Internal; Q1]  

    Times Cited: 783
  3. 2013

    Scirica, B. M., Bhatt, D. L., Braunwald, E., Steg, P. G., Davidson, J., Hirshberg, B., . . . Ueng, K., . . . Savor-Timi Steering Comm, I. (2013). Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus. New England Journal of Medicine, 369(14), 1317-1326. doi:10.1056/NEJMoa1307684. [Journal Category: Medicine, General & Internal; Q1]  

    Times Cited: 1898

    Lin, C. W., Chen, P. N., Chen, M. K., Yang, W. E., Tang, C. H., Yang, S. F., & Hsieh, Y. S. (2013). Kaempferol reduces matrix metalloproteinase-2 expression by down-regulating ERK1/2 and the activator protein-1 signaling pathways in oral cancer cells. Plos One, 8(11). doi:10.1371/journal.pone.0080883. [Journal Category: Multidisciplinary Sciences; Q2]  

    Times Cited: 321
  4. 2014

    Smolen, J. S., Braun, J., Dougados, M., Emery, P., FitzGerald, O., Helliwell, P., . . . Wei, J. C. C., . . . van der Heijde, D. (2014). Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: Recommendations of an international task force. Annals of the Rheumatic Diseases, 73(1), 6-16. doi:10.1136/annrheumdis-2013-203419. [Journal Category: Rheumatology; Q1]  

    Times Cited: 242

    Chen, H. W., Huang, C. S., Li, C. C., Lin, A. H., Huang, Y. J., Wang, T. S., . . . Lii, C. K. (2014). Bioavailability of andrographolide and protection against carbon tetrachloride-induced oxidative damage in rats. Toxicology and Applied Pharmacology, 280(1), 1-9. doi:10.1016/j.taap.2014.07.024. [Journal Category: Toxicology / Pharmacology & Pharmacy; Q1 /Q2]  

    Times Cited: 182
  5. 2016

    Klionsky, D. J., Abdelmohsen, K., Abe, A., Abedin, M. J., Abeliovich, H., Arozena, A. A., . . . Ko, J. L., ... Zughaier, S. M. (2016). Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).Autophagy, 12(1), 1-222. doi:10.1080/15548627.2015.1100356. [Journal Category: Cell Biology; Q1]  

    Times Cited: 2,371

    Zhao, Q. F., Tan, L., Wang, H. F., Jiang, T., Tan, M. S., Tan, L., . . .Lai, T. J., ... Yu, J. T. (2016). The prevalence of neuropsychiatric symptoms in Alzheimer's disease: Systematic review and meta-analysis. Journal of Affective Disorders, 190, 264-271. doi:10.1016/j.jad.2015.09.069. [Journal Category: Clinical Neurology/Psychiatry; Q1]  

    Times Cited: 131

    Lin, J. T., Liu, S. C., Hu, C. C., Shyu, Y. S., Hsu, C. Y., & Yang, D. J. (2016). Effects of roasting temperature and duration on fatty acid composition, phenolic composition, Maillard reaction degree and antioxidant attribute of almond (Prunus dulcis) kernel. Food Chemistry, 190, 520-528. doi:10.1016/j.foodchem.2015.06.004. [Journal Category: Chemistry, Applied/Food Science & Technology/Nutrition & Dietetics; Q1]  

    Times Cited: 54
  6. 2017

    van der Heijde, D., Deodhar, A., Wei, J. C., Drescher, E., Fleishaker, D., Hendrikx, T., . . . Kanik, K. S. (2017). Tofacitinib in patients with ankylosing spondylitis: A phase II, 16-week, randomised, placebo-controlled, dose-ranging study. Annals of the Rheumatic Diseases, 76(8), 1340-1347. doi:10.1136/annrheumdis-2016-210322. [Journal Category: Rheumatology; Q1]  

    Times Cited: 75

    Su, S. C., Hsieh, M. J., Yang, W. E., Chung, W. H., Reiter, R. J., & Yang, S. F. (2017). Cancer metastasis: Mechanisms of inhibition by melatonin. Journal of Pineal Research, 62(1). doi:10.1111/jpi.12370. [Journal Category: Endocrinology & Metabolism/Neurosciences/Physiology; Q1]  

    Times Cited: 121

    Dewey, F. E., Gusarova, V., Dunbar, R. L., O'Dushlaine, C., Schurmann, C., Gottesman, O., . . . Lee, I. T., . . . Baras, A. (2017). Genetic and pharmacologic inactivation of ANGPTL3 and cardiovascular disease. New England Journal of Medicine, 377(3), 211-221. doi:10.1056/NEJMoa1612790. [Journal Category: Medicine, General & Internal; Q1]  

    Times Cited: 165

    Marouli, E., Graff, M., Medina-Gomez, C., Lo, K. S., Wood, A. R., Kjaer, T. R., . . . Lee, I. T., . . . Investigators, M. (2017). Rare and low-frequency coding variants alter human adult height. Nature, 542(7640), 186-190. doi:10.1038/nature21039. [Journal Category: Multidisciplinary Sciences; Q1]  

    Times Cited: 196
  7. 2018

    van der Heijde, D., Wei, J. C. C., Dougados, M., Mease, P., Deodhar, A., Maksymowych, W. P., . . . Grp, C.-V. S. (2018). Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological diseasemodifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial. Lancet, 392(10163), 2441-2451. doi:10.1016/s0140-6736(18)31946-9. [Journal Category: Medicine, General & Internal; Q1]  

    Times Cited: 45

    Baeten, D., Ostergaard, M., Wei, J. C. C., Sieper, J., Jarvinen, P., Tam, L. S., . . . Padula, S. J. (2018). Risankizumab, an IL-23 inhibitor, for ankylosing spondylitis: Results of a randomised, double-blind, placebo-controlled, proof-of-concept, dose-finding phase 2 study. Annals of the Rheumatic Diseases, 77(9), 1295-1302. doi:10.1136/annrheumdis-2018-213328. [Journal Category: Rheumatology; Q1]  

    Times Cited: 59

    Baraliakos, X., Kivitz, J., Deodhar, A. A., Braun, J., Wei, J. C., Delicha, E. M., . . . Grp, M. S. (2018). Long-term effects of interleukin-17A inhibition with secukinumab in active ankylosing spondylitis: 3-year efficacy and safety results from an extension of the Phase 3 MEASURE 1 trial. Clinical and Experimental Rheumatology, 36(1), 50-55. [Journal Category: Rheumatology; Q2]  

    Times Cited: 42

    Schwartz, G. G., Steg, P. G., Szarek, M., Bhatt, D. L., Bittner, V. A., Diaz, R., . . . Ueng, K. C., . . . Inv, O. O. C. (2018). Alirocumab and cardiovascular outcomes after acute coronary syndrome. New England Journal of Medicine, 379(22), 2097-2107. doi:10.1056/NEJMoa1801174. [Journal Category: Medicine, General & Internal; Q1]  

    Times Cited: 363
  8. 2019

    Jukema, J. W., Szarek, M., Zijlstra, L. E., de Silva, H. A., Bhatt, D. L., Bittner, V. A., . . . Ueng, K. C., . . . Investigator, O. O. C. (2019). Alirocumab in patients with polyvascular disease and recent acute coronary syndrome ODYSSEY OUTCOMES trial. Journal of the American College of Cardiology, 74(9), 1167-1176. doi:10.1016/j.jacc.2019.03.013. [Journal Category: Cardiovascular System & Cardiology; Q1]  

    Times Cited: 20

    Ray, K. K., Colhoun, H. M., Szarek, M., Baccara-Dinet, M., Bhatt, D. L., Bittner, V. A., . . . Ueng, K. C., . . . Investigato, O. O. C. (2019). Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: A prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial. Lancet Diabetes & Endocrinology, 7(8), 618-628. doi:10.1016/s2213-8587(19)30158-5. [Journal Category: Endocrinology & Metabolism; Q1]  

    Times Cited: 21

    Steg, P. G., Szarek, M., Bhatt, D. L., Bittner, V. A., Bregeault, M. F., Dalby, A. J., . . . Ueng, K. C., . . . Comm, O. O. (2019). Effect of alirocumab on mortality after acute coronary syndromes an analysis of the ODYSSEY OUTCOMES randomized clinical trial. Circulation, 140(2), 103-112. doi:10.1161/circulationaha.118.038840. [Journal Category: Cardiovascular System & Cardiology; Q1]  

    Times Cited: 16

    Schwartz, G. G., Steg, P. G., Szarek, M., Bhatt, D. L., Bittner, V. A., Diaz, R., . . . Ueng, K. C., . . . Inv, O. O. C. (2018). Alirocumab and cardiovascular outcomes after acute coronary syndrome. New England Journal of Medicine, 379(22), 2097-2107. doi:10.1056/NEJMoa1801174. [Journal Category: Medicine, General & Internal; Q1]  

    Times Cited: 35

學術研究也進入大數據時代,在研究數據快速增長的今天,適當的運用數據分析,將能展現出在過去與現在的研究之間、研究合作者之間、資金和研究影響力之間所存在的珍貴關聯。Web of Science引文索引資料庫精挑細選全球頂尖學術期刊中的研究文獻,以優質、高影響力且獨立公正的引文數據,發現科學創新的研究脈絡與影響力。

學術研究之影響力除了透過「被引用次數」之數據來瞭解外,為更能客觀凸顯出各領域之重要研究文獻,我們針對Web of Science核心合輯之SCIE與SSCI中所收錄的科學及社會科學期刊論文將其領域單一化,進行同年度、同學科領域之統計分析。高被引研究可分為以下兩類:

高被引論文 (Highly Cited Paper)
過去10年間,於同學科領域中,各領域總被引用次數最高的前1%的論文,即為高被引論文 (Highly Cited Papers)。

熱門論文 (Hot Papers)
過去2年間,於同學科領域中,各領域總被引用次數最高的前0.1%的論文,即為熱門研究論文 (Hot Papers)。

Web of Science資料庫超過50年來維持一致品質和水準,獨立執行評選作業並中立於任何出版機構之外,編輯團隊所遴選並評審的期刊,普遍受到全球相關領域的意見領袖、基金和評估機構的重視與信賴,故無論Highly Cited Papers或Hot Papers皆代表具高度的學術影響力。

高被引研究作者群
Author

中山醫學大學於過去10年間共有30篇高被引研究,
以下為本校入選為Highly Cited Papers或Hot Papers之校內重要研究,讓我們來看看有哪些表現優異的研究人員吧!

魏正宗博士

Wei, JCC (Wei, James Cheng-Chung)

中山醫學大學醫學研究所 教授
中山醫學大學附設醫院過敏免疫風濕科 主任
 

翁國昌博士

Ueng, KC (Ueng, Kwo-Chang)

中山醫學大學醫學系 教授
中山醫學大學附設醫院心臟內科 主治醫師
 

楊順發博士

Yang, SF (Yang, Shun-Fa)

中山醫學大學研究發展處 研發長
中山醫學大學醫學研究所 教授
中山醫學大學附設醫院臨床研究中心 主任

楊惟恩博士

Yang, WE (Yang, Wei-En)

中山醫學大學附設醫院臨床研究中心 研究員
 

李奕德博士

Lee, IT (Lee, I-T.)

中山醫學大學醫學系 兼任副教授
台中榮民總醫院新陳代謝科 主任

柯俊良博士

Ko, JL (Ko, Jiunn-Liang)

中山醫學大學醫學研究所 教授
 

賴德仁博士

Lai, TJ (Lai, Te-Jen)

中山醫學大學醫學研究所 教授
 

林昭田博士

Lin, JT (Lin, Jau-Tien)

中山醫學大學醫學應用化學系 教授
 

劉世詮博士

Liu, SC (Liu, Shih-Chun)

中山醫學大學健康餐飲暨產業管理學系 副教授
 

胡超群博士

Hu, CC (Hu, Chao-Chin)

中山醫學大學醫學應用化學系 助理教授
 

王祖興博士

Wang, TS (Wang, Tsu-Shing)

中山醫學大學圖書資訊處 圖資長
中山醫學大學生物醫學科學學系 教授

李健群博士

Li, CC (Li, Chien-Chun)

中山醫學大學營養學系 副教授
 

林巧雯博士

Lin, CW (Lin, Chiao-Wen)

中山醫學大學口腔科學研究所 教授
 

謝易修博士

Hsieh, YS (Hsieh, Yih-Shou)

中山醫學大學生化微生物免疫研究所 所長
中山醫學大學生化微生物免疫研究所 教授

陳霈霓博士

Chen, PN (Chen, Pei-Ni)

中山醫學大學生化微生物免疫研究所 助理教授
 

李孟智博士

Lee, MC (Lee, Meng-Chih)

中山醫學大學醫學研究所 教授